Skip to main content

In vitro activity of azithromycin against Mycoplasma genitalium and its efficacy in the treatment of male Mycoplasma genitalium-positive nongonococcal urethritis

Abstract

Many recent studies have shown that Mycoplasma genitalium is among the pathogens responsible for Chlamydia trachomatis-negative nongonococcal urethritis (NGU). A single 1-g dose of azithromycin (AZM) has been recommended for the treatment of NGU, including M. genitalium-positive NGU, irrespective of whether it is positive or negative for Chlamydia trachomatis. The purpose of this study was to determine the minimal inhibitory concentrations of AZM against Mycoplasma genitalium strains, and to assess its clinical efficacy against Mycoplasma genitalium-positive NGU. Seven Mycoplasma genitalium strains were obtained from the American Type Culture Collection, and susceptibility testing of seven antimicrobial agents was performed using a broth microdilution method. Thirty men with M. genitalium-positive NGU were enrolled in this study and treated with a single 1-g dose of AZM. AZM and clarithromycin (CAM) were highly active against M. genitalium strains. Fluoroquinolone activities were moderate, and of the three fluoroquinolones tested, gatifloxacin (GFLX) and sparfloxacin (SPFX) were more active than levofloxacin (LVFX). In 25 of 30 (83.3%) men treated with a single 1-g dose of AZM, M. genitalium was eradicated from first-void urine samples, as determined by polymerase chain reaction. AZM was highly active against M. genitalium, and a single 1-g dose of AZM for M. genitalium-positive NGU was tolerated in Japan. These findings may be helpful in establishing optimal treatment for M. genitalium-positive NGU.

This is a preview of subscription content, access via your institution.

References

  1. Horner PJ, Gilroy CB, Thomas BJ, Naidoo RO, Taylor-Robinson D. Association of Mycoplasma genitalium with acute non-gonococcal urethritis. Lancet. 1993;342:582–5.

    PubMed  Article  CAS  Google Scholar 

  2. Deguchi T, Maeda SI. Mycoplasma genitalium: another important pathgen of nongonococcal urethritis. J Urol. 2002;167:1210–7.

    PubMed  Article  Google Scholar 

  3. Ross JDC, Jensen JS. Mcoplasma genitalium as a sexually transmitted infection: implications for screening, testing, and treatment. Sex Transm Infect. 2006;82:269–71.

    PubMed  Article  CAS  Google Scholar 

  4. Maeda SI, Tamaki M, Kojima K, Yoshida T, Ishiko H, Yasuda M, et al. Association of Mycoplasma genitalium persistence in the urethra with recurrence of nongonococcal urethritis. Sex Transm Dis. 2001;28:472–6.

    PubMed  Article  CAS  Google Scholar 

  5. Renaudin H, Tully JG, Bebear C. In vitro susceptibilities of Mycoplasma genitalium to antibiotics. Antimicrob Agents Chemother. 1992;36:870–2.

    PubMed  CAS  Google Scholar 

  6. Pereyre S, Renaudin H, Bebear C, Bebear CM. In vitro activities of the newer quinolones garenoxacin, gatifloxacin, and gemifloxacin against human mycoplasmas. Antimicrob Agents Chemother. 2004;48:3165–8.

    PubMed  Article  CAS  Google Scholar 

  7. Hannan PC, Woodnutt G. In vitro activity of gemifloxacin (SB 265805; LB20304a) against human mycoplasmas. J Antimicrob Chemother. 2000;45:367–9.

    PubMed  Article  CAS  Google Scholar 

  8. Waites KB, Crabb DM, Duffy LB. Comparative in vitro susceptibilities of human mycoplasmas and ureaplasmas to a new investigational ketolide, CEM-101. Antimicrob Agents Chemother. 2009;53:2139–41.

    PubMed  Article  CAS  Google Scholar 

  9. Hamasuna R, Jensen JS, Osada Y. Antimicrobial susceptibilites of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR. Antimicrob Agents Chemother. 2009;53:4938–9.

    PubMed  Article  CAS  Google Scholar 

  10. US CDC. Sexually transmitted disease treatment guidelines, 2010. Morb Mortal Wkly Rep. 2010; 59:1–116.

  11. Bjornelius E, Anagrius C, Bojs G, Carlberg H, Johannisson G, Johannisson E, et al. Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: a controlled clinical trial. Sex Transm Infect. 2008;84:72–6.

    PubMed  Article  CAS  Google Scholar 

  12. Mena LA, Mroczkowski TF, Nsuami M, Martin DH. A randomized comparsion of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men. Clin Infect Dis. 2009;48:1649–54.

    PubMed  Article  CAS  Google Scholar 

  13. Bradhaw CS, Chen MY, Fairley CK. Persistence of Mycoplasma genitalium following azithromycin therapy. PLoS One. 2008;11:1–6.

    Google Scholar 

  14. Bradshaw C, Jensen JS, Tabrizi S, Read T, Garland S, Hopkins C, et al. Azithromycin failure in Mycoplasma genitalium urethritis. Emerg Infect Dis. 2006;12:1149–52.

    PubMed  CAS  Google Scholar 

  15. Jernberg E, Moghaddam A, Moi H. Azithromycin, moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study. Int J STD AIDS. 2008;19:676–9.

    Google Scholar 

  16. Jensen JS, Tabrizi SN, Fairley CK, Hamasuna R. Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin Infect Dis. 2008;47:1546–53.

    PubMed  Article  CAS  Google Scholar 

  17. Hjorth SV, Bjornelius E, Lidbrink P, Falk L, Dohn B, Berthelsen L, et al. Sequence-based typing of Mycoplasma genitalium reveals sexual transmission. J Clin Microbiol. 2006;44:2078–83.

    PubMed  Article  Google Scholar 

  18. Okazaki N, Ohya H, Sasaki T. Mycoplasma pneumoniae isolated from patients with respiratory infection in Kanagawa Prefecture in 1976–2006: emergence of macrolide-resistant strains. J Infect Dis. 2007;60:325–6.

    Google Scholar 

  19. Morozumi M, Takahashi T, Ubukata K. Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J Infect Chemother. 2010;16:78–86.

    PubMed  Article  Google Scholar 

  20. Takahashi S, Matsukawa M, Kurimura Y, Takeyama K, Kunishima Y, Iwasawa A, et al. Clinical efficacy of azithromycin for male nongonococcal urethritis. J Infect Chemother. 2008;14:409–12.

    PubMed  Article  CAS  Google Scholar 

  21. Takahashi S, Ichihara K, Hashimoto J, Kurimura Y, Iwasawa A, Hayashi K, et al. Clinical efficacy of levofloxacin 500 mg once daily for 7 days for patients with non-gonococcal urethritis. J Infect Chemother. 2011;17:392–6. doi: 10.1007/s10156-010-0192-z

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Noriyasu Hagiwara.

About this article

Cite this article

Hagiwara, N., Yasuda, M., Maeda, Si. et al. In vitro activity of azithromycin against Mycoplasma genitalium and its efficacy in the treatment of male Mycoplasma genitalium-positive nongonococcal urethritis. J Infect Chemother 17, 821–824 (2011). https://doi.org/10.1007/s10156-011-0269-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10156-011-0269-3

Keywords

  • Mycoplasma genitalium
  • Nongonococcal urethritis
  • Azithromycin